tiprankstipranks
Matinas announces in vivo safety data with oral LNC-doxetaxel formulation
PremiumThe FlyMatinas announces in vivo safety data with oral LNC-doxetaxel formulation
24d ago
Matinas BioPharma’s LNC Technology Promises Safer Chemotherapy
PremiumCompany Announcements
Matinas BioPharma’s LNC Technology Promises Safer Chemotherapy
24d ago
Matinas BioPharma Announces Positive in vivo Safety Data with its Oral LNC-Docetaxel Formulation
PremiumPress Releases
Matinas BioPharma Announces Positive in vivo Safety Data with its Oral LNC-Docetaxel Formulation
24d ago
Matinas BioPharma’s MAT2203 Shows Renal Improvement and Infection Recovery
PremiumCompany AnnouncementsMatinas BioPharma’s MAT2203 Shows Renal Improvement and Infection Recovery
2M ago
Matinas BioPharma provides update from Compassionate/EUA Program with MAT2203
PremiumThe Fly
Matinas BioPharma provides update from Compassionate/EUA Program with MAT2203
2M ago
Matinas BioPharma Advances MAT2203 in Phase 3 Global Trial
PremiumCompany Announcements
Matinas BioPharma Advances MAT2203 in Phase 3 Global Trial
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100